Companies: 10,795·Total market cap: $144.5T
Scorpius Holdings, Inc.

Scorpius Holdings, Inc.

SCPXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$17343
P/E Ratio
52W High$0.15
52W Low$0.0001

Scorpius Holdings, Inc. (SCPX) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

scpx · pe ratio · data through Dec 31, 2024

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Scorpius Holdings, Inc. (SCPX) measures how much investors pay for each dollar of the company's trailing earnings. SCPX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.41.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31

Forward P/E
N/A
FY2026 est. EPS $-342.00
Based on 1 analyst
EPS (TTM)
-$0.41
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Scorpius Holdings, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2015 – 2024 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Scorpius Holdings, Inc.
Scorpius Holdings, Inc.You
SCPX
$0MN/A-$0.41
Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc.
AMPE
$0MN/A-$10.67
Bioasis Technologies Inc.
Bioasis Technologies Inc.
BIOAF
$0MN/A-$0.04
Banyan Corp.
Banyan Corp.
BNYN
$0MN/A-$17.79
Easy Technologies Inc.
Easy Technologies Inc.
EMYSF
$0MN/A-$0.07
GB Sciences, Inc.
GB Sciences, Inc.
GBLX
$0MN/A-$0.00
GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation
GSTC
$0MN/A-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 10 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2024-12-31Latest
FY2024
$-13.04
2023-12-31
FY2023
$-347.20
2022-12-31
FY2022
$-339.25
2021-12-31
FY2021
$-281.54
2020-12-31
FY2020
$-325.98
2019-12-31
FY2019
$-842.06
2018-12-31
FY2018
$-1259.82
2017-12-31
FY2017
$-4311.28
2016-12-31
FY2016
$-10009.85
2015-12-31
FY2015
$-35446.74

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Scorpius Holdings, Inc. (SCPX) measures how much investors pay for each dollar of the company's trailing earnings. SCPX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.41.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.41 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

SCPX pe ratio · 6 questions

SCPX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.41. Data sourced from Financial Modeling Prep via SCPX's SEC 10-K and 10-Q filings.

SCPX PE ratioWhat is SCPX PE ratioCurrent PE ratio of SCPXSCPX PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Scorpius Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09